Literature DB >> 20668076

Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus.

Mohamed S Abdel-Hakeem1, Nathalie Bédard, Gamal Badr, Mario Ostrowski, Rafick P Sékaly, Julie Bruneau, Bernard Willems, E Jenny Heathcote, Naglaa H Shoukry.   

Abstract

Early alpha interferon (IFN-alpha) therapy against hepatitis C virus (HCV) rescues polyfunctional, virus-specific memory CD8(+) T cells, but whether immune restoration is possible during late therapy remains controversial. We compared immune restoration of HCV-specific memory T cells in patients who cleared HCV infection spontaneously and following early or late IFN therapy. Multifunctional CD4(+) and CD8(+) memory T cells were detected in spontaneous resolvers and in individuals treated early following an acute infection. In contrast, limited responses were detected in patients treated during chronic infection, and the phenotype of HCV-specific cells was influenced by autologous viral sequences. Our data suggest that irreversible damage to the HCV-specific memory T-cell response is associated with chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668076      PMCID: PMC2937796          DOI: 10.1128/JVI.01094-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

Review 2.  Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C.

Authors:  Heiner Wedemeyer; Elmar Jäckel; Johannes Wiegand; Markus Cornberg; Michael P Manns
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

Review 3.  Course and outcome of hepatitis C.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.

Authors:  Georg M Lauer; Kei Ouchi; Raymond T Chung; Tam N Nguyen; Cheryl L Day; Deborah R Purkis; Markus Reiser; Arthur Y Kim; Michaela Lucas; Paul Klenerman; Bruce D Walker
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Authors:  Michael W Fried; Mitchell L Shiffman; K Rajender Reddy; Coleman Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moises Diago; Giampiero Carosi; Daniel Dhumeaux; Antonio Craxi; Amy Lin; Joseph Hoffman; Jian Yu
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

6.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

7.  Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

Authors:  Sanaa M Kamal; Jutta Fehr; Bernd Roesler; Thomas Peters; Jens W Rasenack
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

8.  The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection.

Authors:  Eleanor Barnes; Gillian Harcourt; Dave Brown; Michaela Lucas; Rodney Phillips; Geoffrey Dusheiko; Paul Klenerman
Journal:  Hepatology       Date:  2002-09       Impact factor: 17.425

9.  HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.

Authors:  Souheil-Antoine Younes; Bader Yassine-Diab; Alain R Dumont; Mohamed-Rachid Boulassel; Zvi Grossman; Jean-Pierre Routy; Rafick-Pierre Sekaly
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  Progress in defining CD4 helper cell responses in chronic viral infections.

Authors:  Cheryl L Day; Bruce D Walker
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  25 in total

Review 1.  Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

Authors:  Juan-Ramón Larrubia; Elia Moreno-Cubero; Joaquín Miquel; Eduardo Sanz-de-Villalobos
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection.

Authors:  Nina Hensel; Zuguang Gu; Dominik Wieland; Katharina Jechow; Janine Kemming; Sian Llewellyn-Lacey; Emma Gostick; Oezlem Sogukpinar; Florian Emmerich; David A Price; Bertram Bengsch; Tobias Boettler; Christoph Neumann-Haefelin; Roland Eils; Christian Conrad; Ralf Bartenschlager; Dominic Grün; Naveed Ishaque; Robert Thimme; Maike Hofmann
Journal:  Nat Immunol       Date:  2021-01-04       Impact factor: 25.606

Review 3.  Immune and non-immune responses to hepatitis C virus infection.

Authors:  Jiaren Sun; Ricardo Rajsbaum; MinKyung Yi
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

4.  HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin.

Authors:  Yalena Amador-Cañizares; Gillian Martínez-Donato; Liz Alvarez-Lajonchere; Claudia Vasallo; Mariacarla Dausá; Daylen Aguilar-Noriega; Carmen Valenzuela; Ivette Raíces; Jean Dubuisson; Czeslaw Wychowski; Zurina Cinza-Estévez; Marlén Castellanos; Magdalys Núñez; Anny Armas; Yaimé González; Ismariley Revé; Ivis Guerra; Angel Pérez Aguiar; Santiago Dueñas-Carrera
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 5.  Reversing immune dysfunction and liver damage after direct-acting antiviral treatment for hepatitis C.

Authors:  Sabrina Mazouz; Maude Boisvert; Naglaa H Shoukry; Daniel Lamarre
Journal:  Can Liver J       Date:  2018-07-17

6.  Signatures of protective memory immune responses during hepatitis C virus reinfection.

Authors:  Mohamed S Abdel-Hakeem; Nathalie Bédard; Donald Murphy; Julie Bruneau; Naglaa H Shoukry
Journal:  Gastroenterology       Date:  2014-07-16       Impact factor: 22.682

7.  Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.

Authors:  Jacqueline K Flynn; Gregory J Dore; Margaret Hellard; Barbara Yeung; William D Rawlinson; Peter A White; John M Kaldor; Andrew R Lloyd; Rosemary A Ffrench
Journal:  J Gastroenterol Hepatol       Date:  2013-11       Impact factor: 4.029

8.  CD4+ T cell restoration and control of hepatitis C virus replication after childbirth.

Authors:  Samantha L Coss; Almudena Torres-Cornejo; Mona R Prasad; Melissa Moore-Clingenpeel; Arash Grakoui; Georg M Lauer; Christopher M Walker; Jonathan R Honegger
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

9.  Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.

Authors:  Desarae Echevarria; Alexander Gutfraind; Basmattee Boodram; Marian Major; Sara Del Valle; Scott J Cotler; Harel Dahari
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

10.  T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.

Authors:  Benoit Callendret; Heather B Eccleston; Shelby Hall; William Satterfield; Stefania Capone; Antonella Folgori; Riccardo Cortese; Alfredo Nicosia; Christopher M Walker
Journal:  Hepatology       Date:  2014-09-25       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.